Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Kabelitz

Showing results (11-20 of 229) with videos related to

Pageof 23
Sort By:
Recent Patents on Anti-Infective Drug Discovery|July 24, 2015
PrefaceDieter Kabelitz
Clinical Immunology (Orlando, Fla.)|July 23, 2016
Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30years of γδ T cell researchDieter Kabelitz
European Journal of Cell Biology|December 15, 2010
The German Collaborative Research Center 415 "specificity and pathophysiology of signal transduction pathways"Dieter Kabelitz
Blood|September 15, 2012
CD277 takes the lead in human γδ T-cell activationDieter Kabelitz
Cancer Immunology Research|October 30, 2024
BTN2A1: A Novel Target to Boost Tumor Killing Capacity of Human γδ T CellsDieter Kabelitz
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Immunology: new approaches to immuno-modulation and immunotherapy]Dieter Kabelitz
F1000 Medicine Reports|October 16, 2010
Human γδ T lymphocytes for immunotherapeutic strategies against cancerDieter Kabelitz
Signal Transduction and Targeted Therapy|June 29, 2025
Modification of lysine residues in proteins: a novel posttranslational effect of vitamin CDieter Kabelitz
Medizinische Monatsschrift Fur Pharmazeuten|August 3, 2012
[Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention]Dieter Kabelitz
Blood|May 8, 2025
STING activation enhances immunotherapy of AMLDieter Kabelitz, Guranda Chitadze
Pageof 23

Showing results (11-20 of 229) with videos related to

Sort By:
Pageof 23
Recent Patents on Anti-Infective Drug Discovery|July 24, 2015
PrefaceDieter Kabelitz
Clinical Immunology (Orlando, Fla.)|July 23, 2016
Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30years of γδ T cell researchDieter Kabelitz
European Journal of Cell Biology|December 15, 2010
The German Collaborative Research Center 415 "specificity and pathophysiology of signal transduction pathways"Dieter Kabelitz
Blood|September 15, 2012
CD277 takes the lead in human γδ T-cell activationDieter Kabelitz
Cancer Immunology Research|October 30, 2024
BTN2A1: A Novel Target to Boost Tumor Killing Capacity of Human γδ T CellsDieter Kabelitz
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Immunology: new approaches to immuno-modulation and immunotherapy]Dieter Kabelitz
F1000 Medicine Reports|October 16, 2010
Human γδ T lymphocytes for immunotherapeutic strategies against cancerDieter Kabelitz
Signal Transduction and Targeted Therapy|June 29, 2025
Modification of lysine residues in proteins: a novel posttranslational effect of vitamin CDieter Kabelitz
Medizinische Monatsschrift Fur Pharmazeuten|August 3, 2012
[Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention]Dieter Kabelitz
Blood|May 8, 2025
STING activation enhances immunotherapy of AMLDieter Kabelitz, Guranda Chitadze
Pageof 23